These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 32274211

  • 21. Risk Factors for Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Abnormalities in a Chinese Pediatric Population With Kawasaki Disease: A Retrospective Cohort Study.
    Liu J, Huang Y, Chen C, Su D, Qin S, Pang Y.
    Front Pediatr; 2022; 10():812644. PubMed ID: 35515347
    [Abstract] [Full Text] [Related]

  • 22. Risk factors and coronary artery outcomes of coronary artery aneurysms differing in size and emergence time in children with Kawasaki disease.
    Liu J, Yue Q, Qin S, Su D, Ye B, Pang Y.
    Front Cardiovasc Med; 2022; 9():969495. PubMed ID: 36158849
    [Abstract] [Full Text] [Related]

  • 23. Utility of color Doppler echocardiography combined with clinical markers in diagnosis and prediction of prognosis of coronary artery lesions in Kawasaki disease.
    Xue M, Wang J.
    Exp Ther Med; 2020 Apr; 19(4):2597-2603. PubMed ID: 32256739
    [Abstract] [Full Text] [Related]

  • 24. Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease.
    Li W, Zhang L, Wang Z, He X, Lin H, Wang Y, Yuan J, Xie X, Zhang X, Qin Y, Huang P.
    Int J Clin Pract; 2022 Apr; 2022():2726686. PubMed ID: 35989868
    [Abstract] [Full Text] [Related]

  • 25. Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease.
    Park HM, Lee DW, Hyun MC, Lee SB.
    Korean J Pediatr; 2013 Feb; 56(2):75-9. PubMed ID: 23482814
    [Abstract] [Full Text] [Related]

  • 26. Correlation Analysis of Anti-Cardiolipin Antibody/D Dimer/C-Reactive Protein and Coronary Artery Lesions/Multiple-Organ Damage in Children With Kawasaki Disease.
    Xu YM, Chu YQ, Wang H.
    Front Pediatr; 2021 Feb; 9():704929. PubMed ID: 34660478
    [Abstract] [Full Text] [Related]

  • 27. Effect of different doses of aspirin on the prognosis of Kawasaki disease.
    Wang J, Chen H, Shi H, Zhang X, Shao Y, Hang B, Xu Z, Rong X, Chu M, Qiu H.
    Pediatr Rheumatol Online J; 2020 Jun 11; 18(1):48. PubMed ID: 32527316
    [Abstract] [Full Text] [Related]

  • 28. Clinical features analysis of Kawasaki disease with abdominal symptoms as the first manifestation.
    Yang P, Mao Z, Sun M, Guo J.
    Eur J Pediatr; 2023 Sep 11; 182(9):4049-4057. PubMed ID: 37394531
    [Abstract] [Full Text] [Related]

  • 29. Neutrophil-to-lymphocyte ratio and scoring system for predicting coronary artery lesions of Kawasaki disease.
    Chang LS, Lin YJ, Yan JH, Guo MM, Lo MH, Kuo HC.
    BMC Pediatr; 2020 Aug 24; 20(1):398. PubMed ID: 32838756
    [Abstract] [Full Text] [Related]

  • 30. Correlation between the Level of Inflammatory Cytokines and Prognosis in Children with IVIG-sensitive Kawasaki Disease and IVIG-resistant Kawasaki Disease.
    Zhang H, Song HB, Wang DX, Deng HY, Sun WL.
    Pak J Med Sci; 2022 Aug 24; 38(5):1165-1169. PubMed ID: 35799766
    [Abstract] [Full Text] [Related]

  • 31. Clinical indicators combined with S100A12/TLR2 signaling molecules to establish a new scoring model for coronary artery lesions in Kawasaki disease.
    Wu Y, Wang S, Zhou Y, Yang Y, Li S, Yin W, Ding Y.
    PLoS One; 2023 Aug 24; 18(10):e0292653. PubMed ID: 37824465
    [Abstract] [Full Text] [Related]

  • 32. AST to ALT ratio and risk of hemorrhagic transformation in patients with acute ischemic stroke.
    Wang Y, Qiu K, Song Q, Cheng Y, Liu J, Liu M.
    Neurol Res; 2020 Nov 24; 42(11):980-986. PubMed ID: 32697140
    [Abstract] [Full Text] [Related]

  • 33. [Expression of sICAM-1 in children with intravenous immunoglobulin-resistant Kawasaki disease].
    Liu F, Ding Y, Yin W.
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec 24; 15(12):1109-12. PubMed ID: 24342209
    [Abstract] [Full Text] [Related]

  • 34. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T, Ohara T, Muto T, Okumura A, Baba R, Koizumi Y, Yamagishi Y, Mikamo H, Daigo K, Hamakubo T.
    Front Immunol; 2021 Dec 24; 12():624802. PubMed ID: 33912155
    [Abstract] [Full Text] [Related]

  • 35. Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study.
    Zhang X, He Y, Shao Y, Hang B, Xu Z, Chu M.
    Pediatr Rheumatol Online J; 2021 Jun 26; 19(1):96. PubMed ID: 34174872
    [Abstract] [Full Text] [Related]

  • 36. Reevaluation of the efficacy of intravenous gammaglobulin in the prevention and treatment of coronary artery lesion in Kawasaki disease.
    Qin L, Saumu MT, Wang H, Shi H, Hu X, Cheng P.
    J Huazhong Univ Sci Technolog Med Sci; 2005 Jun 26; 25(3):348-50, 370. PubMed ID: 16201293
    [Abstract] [Full Text] [Related]

  • 37. [Clinical features of Kawasaki disease complicated by macrophage activation syndrome: an analysis of 27 cases].
    Wen YN, Chen J, Liu F, Ding Y, Yin W.
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jun 15; 25(6):572-578. PubMed ID: 37382125
    [Abstract] [Full Text] [Related]

  • 38. Predictive factors of resistance to intravenous immunoglobulin and coronary artery lesions in Kawasaki disease.
    Lee HY, Song MS.
    Korean J Pediatr; 2016 Dec 15; 59(12):477-482. PubMed ID: 28194213
    [Abstract] [Full Text] [Related]

  • 39. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
    Shao S, Zhou K, Liu X, Liu L, Wu M, Deng Y, Duan H, Li Y, Hua Y, Wang C.
    J Clin Endocrinol Metab; 2021 Sep 27; 106(10):e4210-e4220. PubMed ID: 33837779
    [Abstract] [Full Text] [Related]

  • 40. Age-adjusted plasma N-terminal pro-brain natriuretic peptide level in Kawasaki disease.
    Jun H, Ko KO, Lim JW, Yoon JM, Lee GM, Cheon EJ.
    Korean J Pediatr; 2016 Jul 27; 59(7):298-302. PubMed ID: 27588030
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.